C12Y 114/15006
Cholesterol monooxygenase , i.e. cytochrome p450scc
Official title: Cholesterol monooxygenase (side-chain-cleaving) (1.14.15.6), i.e. cytochrome P450scc
C12Y114/15006 (Cholesterol monooxygenase , i.e. cytochrome p450scc) appears on 18 US grants and 18 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 18
- Assignees
- 17
- Inventors
- 51
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 2 | 2 |
| 2024 | 1 | 1 |
| 2025 | 1 | 2 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeted expression of microbial cholesterol catalysis genes reduces excess lipid10 Feb 2026US 12,544,402 B2Repair Biotechnologies, Inc.
- Enabling cholesterol catabolism in mammalian cells lacking same10 Feb 2026US 12,545,918 B2University of South Alabama Foundation for Research and Commercialization
- Cytochrome P450 monooxygenase catalyzed oxidation of sesquiterpenes4 Mar 2025US 12,241,110 B2
- Regioselective hydroxylation of isophorone3 Sep 2024US 12,077,801 B2Dsm IP Assets B.V.
- Micheliolide derivatives, methods for their preparation and their use as anticancer and antiinflammatory agents25 Apr 2023US 11,634,400 B2University of Rochester
- Fusion protein and use for bioconverting molecules16 Oct 2025US 2025/0320469 A1Centre National De La Recherche Scientifique
- Cytochrome p450 monooxygenase catalyzed oxidation of sesquiterpenes22 May 2025US 2025/0163477 A1Firmenich SA
- Enhancing mitochondrial-based flow and catabolism of cholesterol15 Feb 2024US 2024/0050592 A1Repair Biotechnologies, Inc.
- Enabling cholesterol catabolism in human cells24 Aug 2023US 2023/0263829 A1University of South Alabama Foundation for Research and Commercialization
- Cytochrome p450 monooxygenase catalyzed oxidation of sesquiterpenes18 May 2023US 2023/0151393 A1Firmenich SA
Most cited
By later US patents
- Yeast strains autonomously producing steroids13US 7,670,829 B2Aventis Pharma S. A. · 2010
- Cholesterol disposal fusion enzymes12US 5,547,868 AThe Regents of the University of California · 1996
- Cholesterol disposal fusion enzymes6US 5,939,318 AThe Regents of the University of California · 1999
- Cloned DNA for P450scc and expression thereof4US 5,045,471 AThe Regents of the University of California · 1991
- Compostions and methods for enabling cholesterol catabolism in human cells2US 11,612,619 B2National Institute of Health (NIH), U.S. Dept. Of Health and Human Services (DHHS), U.S. Government · 2023